Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
chemokine upregulated in ischemic brain tissue [RGD, Feb 2006].. Additionally we are shipping CCL20 Kits (87) and CCL20 Proteins (76) and many more products for this protein.
Showing 10 out of 141 products:
Human Polyclonal CCL20 Primary Antibody for IHC, Neut - ABIN401107
Reboldi, Coisne, Baumjohann, Benvenuto, Bottinelli, Lira, Uccelli, Lanzavecchia, Engelhardt, Sallusto: C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. in Nature immunology 2009
Show all 3 references for ABIN401107
Rat (Rattus) Polyclonal CCL20 Primary Antibody for WB - ABIN610566
Reeves, Helman, Allison, Israel: Molecular cloning and primary structure of human glial fibrillary acidic protein. in Proceedings of the National Academy of Sciences of the United States of America 1989
Human Polyclonal CCL20 Primary Antibody for ELISA, WB - ABIN1043800
Lisignoli, Manferdini, Codeluppi, Piacentini, Grassi, Cattini, Filardo, Facchini: CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. in Journal of cellular physiology 2009
Mouse (Murine) Polyclonal CCL20 Primary Antibody for ELISA, WB - ABIN1043828
Harper, Guo, Rizzo, Lillis, Kurtz, Skorcheva, Purdy, Fitch, Iordanov, Blauvelt: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. in The Journal of investigative dermatology 2009
Hypoxia is a transcriptional inducer of CCL20 in human mononuclear phagocytes.
Both MIP-3alpha and cystatin A (show CSTA Antibodies) overexpressions in NPC (show NPC1 Antibodies) tumor tissues were strong independent factors of poor prognosis in NPC (show NPC1 Antibodies) patients.
High-risk HPV-type lesions might inhibit the chemokine (show CCL1 Antibodies) CCL20 on Langerhans cells through E6 and E7 to escape the immune response.
High CCL20 expression is associated with Inflammatory Bowel Disease.
Tregs of unexplained recurrent miscarriage patients was significantly lower than that in controls. CCL20-CCR6 (show CCR6 Antibodies) could drive immune activity of CD4 (show CD4 Antibodies)(+)FOXP3 (show FOXP3 Antibodies)(+) Tregs, followed by their migration to the feto-maternal microenvironment
human lung epithelial cells secrete CCL20 and BD2 (show DEFB4 Antibodies) in response to B (show TDO2 Antibodies). abortus and/or to cytokines produced by infected monocytes.
AEG-1 (show MTDH Antibodies) mediates CCL20/CCR6 (show CCR6 Antibodies)-induced EMT (show ITK Antibodies) development via both Erk1/2 (show MAPK1/3 Antibodies) and Akt (show AKT1 Antibodies) signaling pathway in cervical cancer, which indicates that CCL20/CCR6 (show CCR6 Antibodies)-AEG-1 (show MTDH Antibodies)-EMT (show ITK Antibodies) pathway could be suggested as a useful target to affect the progression of cervical cancer.
CCL20 enhanced osteoblast-mediated osteoclastogenesis, partly via IL-6 (show IL6 Antibodies) production, suggesting that CCL20 may contribute to osteoporosis in rheumatoid arthritis by affecting bone cell communication.
two inflammatory cytokines, MIP (show TNPO1 Antibodies)-1delta and MIP-3alpha, are able to increase mesenchymal stromal cells migration in vitro
Th17 cells are recruited into tumor tissues preferentially through CCR6 (show CCR6 Antibodies)-CCL20 pathway
High CCL20 expression is associated with colon cancer.
Data (including data from studies in knockout/mutant mice) suggest that expression of Ahr (aryl-hydrocarbon receptor (show AHR Antibodies)) and its translocation into nucleus are necessary for Ahr (show AHR Antibodies) ligand-mediated synergistic induction of Ccl20; here, TCDD is Ahr (show AHR Antibodies) ligand.
alpha-hemolytic streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells.
Acquired mtDNA mutations may promote tumorigenic phenotypes through up-regulation of chemokine (show CCL1 Antibodies) CCL20.
Overexpression of CCL20 in human proximal tubular cells is inhibited by blockade of KCa3.1 (show KCNN4 Antibodies) under diabetic conditions through inhibition of the NF-kappaB (show NFKB1 Antibodies) pathway.
Our data indicate that estradiol is important in regulating the effects of keratinocyte growth factor (show FGF7 Antibodies) on mouse uterine epithelial cell secretion of CCL20 and CXCL1 (show CXCL1 Antibodies).
CCL20 blockage lead to a diminished cerebral immune response in experimental pneumococcal meningitis.
This study suggests that CCL20/IL-15 (show IL15 Antibodies) can induce a strong antitumor immune response in tumor tissues and it is a suitable candidate for cancer immunotherapy.
Estrogen receptors alpha regulates CCL20/CXCL1 (show CXCL1 Antibodies) secretion in the female reproductive tract.
Cardiac fibroblasts could recruit Th17 cells infiltration into myocardium by secreting CCL20 in acute viral myocarditis.
Data indicate that a CCR6 (show CCR6 Antibodies)/CCL20 chemokine (show CCL1 Antibodies) loop instructed rapid increase of B cells in the spleen in response to systemic administration of Nod1 (show NOD1 Antibodies) agonists in a TNF-alpha (show TNF Antibodies)-dependent manner.
chemokine upregulated in ischemic brain tissue
C-C motif chemokine 20
, maacrophage inflammatory protein 3alpha
, CC chemokine ligand 20
, chemokine (C-C motif) ligand 20
, chemokine CCL20/MIP-3ALPHA
, chemokine CCL-C24a
, CC chemokine LARC
, beta chemokine exodus-1
, liver and activation-regulated chemokine
, macrophage inflammatory protein 3 alpha
, small inducible cytokine subfamily A (Cys-Cys), member 20
, small-inducible cytokine A20
, CC chemokine ST38
, beta-chemokine exodus-1
, small inducible cytokine subfamily A20